METTL15 and cancer: Subsequently, functional assays proved that circ-METTL15 silencing impaired the malignancy of cancer cells, while circ-METTL15 overexpression stimulated PTC malignant progression, hinting that circ-METTL15 could not only be a promising diagnostic biomarker but also a therapeutic target for PTC.